Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
71.95
-1.87 (-2.53%)
Mar 25, 2025, 4:00 PM EST - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $9.26 billion as of March 25, 2025. Its market cap has increased by 17.48% in one year.
Market Cap
9.26B
Enterprise Value
7.58B
1-Year Change
17.48%
Ranking
Category
Stock Price
$71.95
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $9.26B, an increase of 570.89%. That is a compound annual growth rate of 48.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2025 | 9.26B | -9.26% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 773.59B |
| UnitedHealth Group | 471.40B |
| Johnson & Johnson | 393.10B |
| AbbVie | 366.99B |
| Novo Nordisk | 340.37B |
| Merck & Co. | 232.33B |
| AstraZeneca | 229.25B |
| Novartis AG | 221.84B |